Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation...

Related Keywords

United States ,American ,John Mullaly ,Jamesp Allison ,Michaela Curran ,Jacques Bouchy ,Patricia Lorusso ,Do Yale School Of Medicine Cancer Center ,Linkedin ,Kineta Inc ,Phasei Clinical Trials Program ,Nasdaq ,American Cancer Society Levy Fellowship ,Facebook ,Memorial Sloan Kettering Cancer Center ,Eisenberg Center ,Lifesci Advisors ,Cancer Center ,Yale Cancer Center ,Investor Relations Business Development ,Phd Md Anderson Cancer Center ,Exchange Commission ,Wayne State University Barbara Karmanos Cancer Institute ,Department Of Immunology ,Stanford University ,Clinical Cancer Research ,Key Opinion Leader ,Fireside Chat ,Yale School ,Medicine Cancer Center ,Medical Oncology ,Associate Cancer Center Director ,Experimental Therapeutics ,Yale Cancer ,Wayne State University ,Barbara Karmanos Cancer Institute ,Investigational New Drugs ,Private Securities Litigation Reform Act ,Current Report ,Business Development ,Sci Advisors ,Nasdaq Ka ,Vineta ,Nc ,